We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190 → 266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$114M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$103M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$74.2M
4
FFM
Fairmount Funds Management
Pennsylvania
+$71.2M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$70M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$231M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$201M
3
State Street
State Street
Massachusetts
-$108M
4
MC
Maverick Capital
Texas
-$48M
5
Morgan Stanley
Morgan Stanley
New York
-$47M
Name Holding Trade Value Shares
Change 		Change in
Stake
KFS
251
Kelly Financial Services
Massachusetts
$1.89K – – –
SPIA
252
Steward Partners Investment Advisory
New York
$1.89K – – –
GI
253
Gradient Investments
Minnesota
$1.89K +$1.18K +100 New
IA
254
IFP Advisors
Florida
$1.32K – – –
EWA
255
EverSource Wealth Advisors
Alabama
$1.3K +$815 +69 New
SWA
256
SOA Wealth Advisors
New York
$1.26K – – –
NMG
257
New Millennium Group
Utah
$1.13K – – –
VCM
258
Versant Capital Management
Arizona
$698 +$437 +37 New
BIA
259
Bell Investment Advisors
California
$661 +$413 +35 New
HI
260
Harbour Investments
Wisconsin
$547 – – –
PA
261
Parallel Advisors
California
$528 -$826 -70 -71%
RG
262
Retirement Group
California
$245 – – –
FFA
263
Farther Finance Advisors
California
$208 +$130 +11 New
CA
264
Crewe Advisors
Utah
$133 +$83 +7 New
HNB
265
Huntington National Bank
Ohio
$19 – – –
Jennison Associates
266
Jennison Associates
New York
– -$8.87M -2,308,596 Closed
LOAMS
267
Lombard Odier Asset Management (Switzerland)
Switzerland
– -$3.03M -790,143 Closed
KCM
268
Kennedy Capital Management
Missouri
– -$768K -200,032 Closed
AA
269
ALPS Advisors
Colorado
– -$572K -148,874 Closed
Marshall Wace
270
Marshall Wace
United Kingdom
– -$439K -114,355 Closed
Parallax Volatility Advisers
271
Parallax Volatility Advisers
California
– -$1.18M -100,000 Closed
CIC
272
Cornercap Investment Counsel
Georgia
– -$205K -53,313 Closed
AWM
273
Apollon Wealth Management
South Carolina
– -$192K -50,000 Closed
ACM
274
Aquatic Capital Management
Illinois
– -$188K -49,000 Closed
MNBTD
275
Moody National Bank Trust Division
Texas
– -$176K -45,860 Closed
8 9 10
11
12

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.